Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine Supplementation in Indonesian Children Undergoing Congenital Heart Disease Surgery
NCT04453761Phase 4Unknown
- Sponsor
- National Cardiovascular Center Harapan Kita
- Start
- Jul 2018
- Primary completion
- Dec 2021
- Modality
- Implantable Devices, Transdermal Patches, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of Neurovit Forte in congenital heart disease (CHD), sponsored by National Cardiovascular Center Harapan Kita. Status: unknown.
02
Drugs
Neurovit Forte
03
Conditions
congenital heart disease (CHD)
Beyond the preview
Go deeper on NCT04453761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04453761.